Workflow
Keravive™
icon
Search documents
BeautyHealth Appoints Philippe Schaison, PharmaD, to Board of Directors
Globenewswire· 2025-11-03 21:05
Global Aesthetics Leader Brings Deep Industry Expertise and Proven Track Record Driving Growth Across Health, Beauty, and Consumer Sectors Philippe Schaison Phillipe Schaison, PharmaD, to has been appointed to serve on The BeautyHealth Company Board of Directors. LONG BEACH, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- The BeautyHealth Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced the appointment of global aesthetics leader, Philippe Schaison, PharmaD, to its Board of Directors ...
BeautyHealth to Report Third Quarter 2025 Financial Results on November 6, 2025
Globenewswire· 2025-10-23 14:00
LONG BEACH, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announced it will report third quarter 2025 financial results after market close on Thursday, November 6, 2025. The Company will host an investor conference call at 4:30 p.m. Eastern Time, following a press release detailing the results. A live webcast of the call can be accessed on the Company’s investor relations website at https://investors.beautyhealth.com, along with ...
BeautyHealth to Report Second Quarter 2025 Financial Results on August 7, 2025
Globenewswire· 2025-07-24 14:00
Core Viewpoint - The Beauty Health Company will report its second quarter 2025 financial results on August 7, 2025, after market close, followed by an investor conference call [1]. Group 1: Financial Reporting - The financial results will be announced in a press release, and an investor conference call is scheduled for 4:30 p.m. Eastern Time on the same day [1]. - A live webcast of the call will be available on the company's investor relations website, with a recording accessible approximately three hours after the call concludes [2]. Group 2: Disclosure Practices - The company utilizes various means to disclose material information, including SEC filings, press releases, public conference calls, and its investor relations website, in compliance with Regulation FD [3]. Group 3: Company Overview - The Beauty Health Company (NASDAQ: SKIN) combines medtech and beauty, providing millions of skin health experiences annually, focusing on consumer relationships with skin and self-confidence [4]. - The company's flagship brands include Hydrafacial™ for hydradermabrasion, SkinStylus™ for microneedling, and Keravive™ for scalp health, aiming to personalize skin health for diverse demographics [4]. - The company emphasizes a commitment to mindful business practices that positively impact communities and the environment [4].
The Beauty Health Company Announces Convertible Debt Refinancing
Globenewswire· 2025-05-21 12:00
Core Viewpoint - The Beauty Health Company has announced a refinancing initiative aimed at strengthening its financial position and extending the maturity of a portion of its existing debt, which will facilitate long-term growth investments [2]. Group 1: Refinancing Details - The company has entered into exchange agreements to swap approximately $413.2 million of existing 1.25% convertible senior notes due 2026 for $250.0 million of new 7.95% convertible senior secured notes due 2028, along with approximately $143.4 million in cash [2]. - The new notes will be senior, secured obligations guaranteed by certain subsidiaries and will bear an interest rate of 7.95% per annum [2]. - The initial conversion rate for the new notes is set at 349.6503 shares per $1,000 principal amount, translating to a conversion price of approximately $2.86 per share [2]. Group 2: Strategic Focus - The CEO emphasized that the refinancing is a critical step in enhancing the company's financial flexibility, allowing for investments in innovation and brand initiatives [2]. - The company aims to improve commercial execution, accelerate product development, and deepen engagement with providers [2]. Group 3: Transaction Advisors - Goldman Sachs is serving as the exclusive financial advisor for the transaction, while Latham & Watkins LLP is acting as transaction counsel [3].
BeautyHealth to Report First Quarter 2025 Financial Results on May 8, 2025
Globenewswire· 2025-04-29 20:00
Core Viewpoint - The Beauty Health Company will report its first quarter 2025 financial results on May 8, 2025, and will host an investor conference call shortly after the announcement [1]. Group 1: Financial Reporting - The financial results will be released after market close on May 8, 2025 [1]. - An investor conference call is scheduled for 4:30 p.m. Eastern Time on the same day [1]. Group 2: Investor Relations - A live webcast of the investor call will be available on the company's investor relations website [2]. - A recording of the call will be accessible approximately three hours after its conclusion [2]. Group 3: Company Overview - The Beauty Health Company (NASDAQ: SKIN) focuses on skin health experiences through its flagship brand Hydrafacial™ and other brands like SkinStylus™ and Keravive™ [4]. - The company aims to personalize skin health for diverse demographics and is committed to positive community and environmental impact [4].